首页> 外文期刊>Current drug delivery >Formulation and evaluation of non-effervescent floating tablets of losartan potassium.
【24h】

Formulation and evaluation of non-effervescent floating tablets of losartan potassium.

机译:氯沙坦钾非泡腾片的配制和评价。

获取原文
获取原文并翻译 | 示例
           

摘要

The aim of the work is to modify the solubility and bioavailability of Losartan potassium, by employing noneffervescent floating drug delivery (tablet dosage forms). Non-effervescent systems are a type of floating drug delivery systems, that have been used to boost the gastric residence and the floatation time in the gastro intestinal tract. The study included formulation of floating tablets using polymers like Chitosan and Karaya gum as matrix forming agents. Accurel(?) MP 1000 was used as floating agent. The tablets were prepared by direct compression technique. FTIR, DSC studies conformed that there was no incompatibility between the polymer and the drug. Tablet preformulation parameters were within the Pharmacopoeial limit. Tablet showed zero lag time, contisnuance of buoyancy for >12 h. The tablet showed good in vitro release. Drug release was through swelling and abided by the gellation mechanism. In vivo X-ray studies depicted that tablets continued to float in the GIT for 12 h. Accelerated stability showed that, tablets were stable for over 6 month. Thus the prepared non-effervescent floating tablet of Losartan potassium can be used for the treatment of hypertension for more than 12 h with single dose administration.
机译:这项工作的目的是通过采用非泡腾性漂浮药物递送(片剂剂型)来改变氯沙坦钾的溶解度和生物利用度。非泡腾系统是一种漂浮的药物输送系统,已被用来提高胃在胃肠道的滞留时间和漂浮时间。该研究包括使用诸如壳聚糖和卡拉亚胶之类的聚合物作为基质形成剂来配制漂浮片剂。 Accurel(MP)MP 1000用作漂浮剂。通过直接压片技术制备片剂。 FTIR,DSC研究表明,聚合物与药物之间不存在不相容性。片剂预制剂参数在药典范围内。平板电脑显示零滞后时间,浮力持续时间大于12小时。该片剂显示出良好的体外释放。药物通过溶胀释放,并遵循凝胶化机制。体内X射线研究表明,片剂持续在GIT中漂浮12小时。加速的稳定性表明,片剂稳定超过6个月。因此,所制备的氯沙坦钾盐非泡腾片可以单次给药用于高血压治疗12小时以上。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号